An investigator-sponsored, open-label, single dose, safety and tolerability study clinical study of a Durasert implant to treat severe OA of the knee.

Trial Profile

An investigator-sponsored, open-label, single dose, safety and tolerability study clinical study of a Durasert implant to treat severe OA of the knee.

Active, no longer recruiting
Phase of Trial: Phase I

Latest Information Update: 11 Sep 2017

At a glance

  • Drugs Dexamethasone (Primary)
  • Indications Osteoarthritis
  • Focus Adverse reactions
  • Most Recent Events

    • 11 Sep 2017 Enrollment of this trial has been completed by Hospital for Special Surgery (HSS), as reported in a pSivida media release. 24-week data from this trial expected in 2018.
    • 11 Sep 2017 Status changed from recruiting to active, no longer recruiting, as reported in a pSivida media release
    • 04 May 2017 According to pSivida media release, the company expects to to report the initial 24-week data by the fourth quarter of 2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top